Organogenesis Holdings (ORGO) Other Operating Expenses (2016 - 2026)

Organogenesis Holdings' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $25.8 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 14.92% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at -$148.1 million (up 45.1% YoY), while the FY2025 annual figure was -$233.3 million, down 1.84% from the prior year.
• Other Operating Expenses was $25.8 million for Q1 2026 at Organogenesis Holdings, up from -$60.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $30.3 million in Q1 2025 to a low of -$263.9 million in Q4 2024.
• Historically, Other Operating Expenses has averaged -$69.5 million across 4 years, with a median of -$56.7 million in 2025.
• Biggest YoY gain for Other Operating Expenses was 77.06% in 2025; the steepest drop was 311.65% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at -$207.7 million in 2023, then decreased by 27.07% to -$263.9 million in 2024, then surged by 77.06% to -$60.5 million in 2025, then jumped by 142.57% to $25.8 million in 2026.
• The last three Other Operating Expenses figures came in at $25.8 million (Q1 2026), -$60.5 million (Q4 2025), and -$56.7 million (Q3 2025), per Business Quant data.